Showing results (521-530 of 579) with videos related to

Sort By:
Pageof 58
JAMA Dermatology|April 12, 2023
Efficacy and Safety of Upadacitinib Treatment in Adolescents With Moderate-to-Severe Atopic Dermatitis: Analysis of the Measure Up 1, Measure Up 2, and AD Up Randomized Clinical TrialsAmy S Paller, Barry Ladizinski, Pedro Mendes-Bastos, et al.
Skin Health and Disease|August 1, 2026
Healthcare resource use, costs and health-related quality of life in the UK-Irish Atopic eczema Systemic Therapy Register (A-STAR): a pilot studyCarlos Chivardi, Elizaveta Gribaleva, Bolaji Coker, et al.
Experimental Dermatology|November 29, 2016
SVEP1 plays a crucial role in epidermal differentiationLiat Samuelov, Qiaoli Li, Ron Bochner, et al.
The Journal of Investigative Dermatology|April 6, 2007
Filaggrin null alleles are not associated with psoriasisYiwei Zhao, Ana Terron-Kwiatkowski, Haihui Liao, et al.
Journal of Medicinal Chemistry|June 27, 2014
Identification, optimization, and pharmacology of acylurea GHS-R1a inverse agonistsWilliam McCoull, Peter Barton, Alastair J H Brown, et al.
Dermatologic Clinics|September 24, 2021
Dermatology COVID-19 Registries: Updates and Future DirectionsEsther E Freeman, Grace C Chamberlin, Devon E McMahon, et al.
American Journal of Clinical Dermatology|September 3, 2025
Efficacy and Safety of Upadacitinib in Patients With Moderate-to-Severe Atopic Dermatitis: Phase 3 Randomized Clinical Trial Results Through 140 WeeksAlan D Irvine, Vimal H Prajapati, Emma Guttman-Yassky, et al.
The Journal of Investigative Dermatology|April 9, 2010
Deletion of Late Cornified Envelope 3B and 3C genes is not associated with atopic dermatitisJudith G M Bergboer, Patrick L J M Zeeuwen, Alan D Irvine, et al.
American Journal of Human Genetics|May 26, 2009
Copy-number mutations on chromosome 17q24.2-q24.3 in congenital generalized hypertrichosis terminalis with or without gingival hyperplasiaMiao Sun, Ning Li, Wu Dong, et al.
JAAD International|November 17, 2022
Comparison of real-world treatment outcomes of systemic immunomodulating therapy in atopic dermatitis patients with dark and light skin typesAngela L Bosma, Wouter Ouwerkerk, Madeline J Heidema, et al.
Pageof 58